Wearable neuro-robotic technology for diabetic neuropathy
One of the most common complications of diabetes is peripheral neuropathy (DPN), a form of damage to the peripheral nerves that leads to the loss of tactile sensations in the feet. This loss of sensation leads to impaired gait, poor balance, and a fivefold increase in the probability of falls and injury and often causes comorbidities like depression and anxiety. Moreover, the damaged nerves cause chronic pain, further worsening this vicious cycle. Unfortunately, the standard of care is limited to pain management, commonly opioids with high addictive risks and severe side effects.
MYNERVA AG is developing a groundbreaking device that restores lost sensory feedback. Force sensors capture information from the foot-ground interaction and convert it into electrical impulses delivered to healthy nerves on the ankle. Years of dedicated research have resulted in an optimally designed placement and shape for the electrodes that are complemented by AI-based algorithms to restore sensation and reduce neuropathic pain. This technology has the potential to transform the lives of patients with DPN and shows promise for other conditions involving sensory loss, including amputations, stroke, and spinal cord injuries.
